We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-2.04%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.3B
AUM Growth
-$1.35B
Cap. Flow
-$95.9M
Cap. Flow %
-0.93%
Top 10 Hldgs %
47.3%
Holding
587
New
27
Increased
58
Reduced
187
Closed
27

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$26.5M
2
SNPS icon
Synopsys
SNPS
+$14.3M
3
PH icon
Parker-Hannifin
PH
+$13.1M
4
DKS icon
Dick's Sporting Goods
DKS
+$12.4M
5
VEEV icon
Veeva Systems
VEEV
+$10.4M

Top Sells

Rank Stock Value
1
WEX icon
WEX
WEX
+$14.8M
2
FISV
Fiserv Inc
FISV
+$11.6M
3
MA icon
Mastercard
MA
+$11.3M
4
PYPL icon
PayPal
PYPL
+$8.43M
5
TJX icon
TJX Companies
TJX
+$7.88M

Sector Composition

Rank Sector Weight
1 Technology 38.85%
2 Healthcare 15.75%
3 Financials 11.64%
4 Consumer Discretionary 10.93%
5 Communication Services 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSC icon
476
American Superconductor
AMSC
$1.56B
$11.8K ﹤0.01%
+633
New +$15.8K
ANSS
477
DELISTED
Ansys
ANSS
$11.4K ﹤0.01%
37
EMN icon
478
Eastman Chemical
EMN
$8.29B
$10.9K ﹤0.01%
138
MNST icon
479
Monster Beverage
MNST
$90.1B
$10.5K ﹤0.01%
356
TPZ
480
Tortoise Electrification Infrastructure ETF
TPZ
$127M
$10.4K ﹤0.01%
542
AEG icon
481
Aegon
AEG
$13.9B
$10.2K ﹤0.01%
1,610
CHTR icon
482
Charter Communications
CHTR
$17.9B
$10.1K ﹤0.01%
30
PCRX icon
483
Pacira BioSciences
PCRX
$945M
$10.1K ﹤0.01%
400
HLN icon
484
Haleon
HLN
$43.2B
$9.72K ﹤0.01%
950
AMTX icon
485
Aemetis
AMTX
$126M
$9.61K ﹤0.01%
+6,961
New +$14.9K
SYM icon
486
Symbotic
SYM
$5.35B
$9.25K ﹤0.01%
+437
New +$11.2K
AMLX icon
487
Amylyx Pharmaceuticals
AMLX
$2.6B
$9.12K ﹤0.01%
1,803
YUMC icon
488
Yum China
YUMC
$16.4B
$8.71K ﹤0.01%
186
QTUM icon
489
Defiance Quantum ETF
QTUM
$5.77B
$8.65K ﹤0.01%
+120
New +$9.71K
SBAC icon
490
SBA Communications
SBAC
$19.4B
$8.51K ﹤0.01%
38
AMP icon
491
Ameriprise Financial
AMP
$49.9B
$8.49K ﹤0.01%
18
-7
-28% -$3.67K
DGX icon
492
Quest Diagnostics
DGX
$26.2B
$8.33K ﹤0.01%
48
AIO
493
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$917M
$7.92K ﹤0.01%
+400
New +$9.42K
RUN icon
494
Sunrun
RUN
$2.37B
$7.23K ﹤0.01%
1,086
BWXT icon
495
BWX Technologies
BWXT
$15.8B
$7.12K ﹤0.01%
+68
New +$7.38K
REAL icon
496
The RealReal
REAL
$1.36B
$6.94K ﹤0.01%
1,202
MPT
497
Medical Properties Trust
MPT
$2.42B
$6.93K ﹤0.01%
1,300
CPRT icon
498
Copart
CPRT
$26.8B
$6.9K ﹤0.01%
113
-95
-46% -$5.35K
DKNG icon
499
DraftKings
DKNG
$12.7B
$6.81K ﹤0.01%
200
CSGP icon
500
CoStar Group
CSGP
$12.4B
$6.55K ﹤0.01%
80

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Loring Wolcott & Coolidge Fiduciary Advisors held 587 positions worth $10.3B, down 12% from $11.6B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2025 filing shows 27 new, 58 increased, 187 reduced and 27 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 7,000 shares worth $579K. The largest sale was WEX, an estimated $14.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2025 buy was iShares 1-3 Year Treasury Bond ETF: 7,000 shares worth $579K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NVIDIA in Q1 2025, an estimated $26.5M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2025 reduction was WEX, cutting an estimated $14.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Universal Health Services in Q1 2025, selling an estimated $3.82M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q1 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 27 new positions and closed 27 in Q1 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 12% quarter-over-quarter to $10.3B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.